Kenneth M. Kent, MD, PhD

Itsik Ben-Dor , MD;

Michael Gaglia Jr., MD;

Microvascular Disease and Injury: Prevention and Therapies

Rajbabu Pakala , MD, PhD;

ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...

ABSTRACT: Background. The...

06/28/2011

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

08/01/2008

Pierre Leimgruber , MD;

Jeffrey Werner , MD;

Philip Reid ;

Impact of Gender on the Incidence and Outcome of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention

Richard R. Heuser , MD, FACC, FACP, FESC, FSCAI;

Jorge A. Belardi , MD, PhD;

Howard A. Cohen , MD;

Tim Fischell: Many centers have spent a lot of money on the 25 or so different distal protection devices available today. We are currently preparing a manuscript on a slightly different, simpler, and considerably less expensive approach to...

Tim Fischell: Many centers have...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Ioannis Iakovou , MD;

George D. Dangas , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Roxana Mehran , MD;

Gary S. Mintz , MD;

Lowell F. Satler , MD;

Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-Segment Elevation Who Undergo Pe

Martin B. Leon , MD;

Martin Fahy , MSc;

Alexandra J. Lansky , MD;

Dale T. Ashby , MBBS, PhD;

Contrast-induced nephropathy (CIN) may occur after percutaneous coronary interventions (PCI), particularly in patients with baseline chronic renal failure (CRF) and diabetes mellitus.1–3 We have reported on the adverse impact of CIN post-PCI...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Ron Waksman , MD;

Zhenyi Xue , MS;

Lowell F. Satler , MD;

Roswitha M. Wolfram , MD;

Safety of Percutaneous Coronary Intervention Alone in Symptomatic Patients with Moderate and Severe Valvular Aortic Stenosis and

Petros Okubagzi , MD;

Rebecca L. Torguson , BS, MPH;

Recent randomized trials have established that patients who present with acute coronary syndrome (ACS) non-ST-elevation myocardial infarction (MI) may be managed with low-molecular weight heparin (LMWH) followed by early angiography and by...

Recent randomized trials have...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Lowell F. Satler , MD;

Pramod K. Kuchulakanti , MD;

Daniel A. Canos , MPH;

Impact of Continued Hospitalization in Patients Pre-treated with Clopidogrel Prior to Coronary Angiography and Undergoing Corona

Ellen E. Pinnow , MS;

Seung-Woon Rha , MD, PhD;

Edouard Cheneau , MD;

Neil J. Weissman , MD;

Rajbabu Pakala , MD, PhD;

Ron Waksman , MD;

Aortic stenosis (AS) is prevalent in 2–7% of the population over 65 years of age.1 Atherosclerotic coronary artery disease (CAD) coexists in 27–43% of patients with AS.2 Management of CAD in patients with AS poses special problems since...

Aortic stenosis (AS) is...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Ron Waksman , MD;

Lowell F. Satler , MD;

Seung-Woon Rha , MD, PhD;

Drug-Eluting Stents versus Repeat Vascular Brachytherapy for Patients with Recurrent In-Stent Restenosis after Failed Intracoron

Pramod K. Kuchulakanti , MD;

Edouard Cheneau , MD;

Robert Lew , MD;

Rajbabu Pakala , MD, PhD;

Emmanouil I. Kapetanakis ;

Elizabeth Haile ;

Paul Corso ;

Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...

Clopidogrel is an oral...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Rebecca L. Torguson , BS, MPH;

Rosanna Chan , PhD;

Michael Porrazzo , MD;

Ron Waksman , MD;

Lowell F. Satler , MD;

Comparative Intravascular Ultrasound Analysis of Ostial Disease in the Left Main versus the Right Coronary Artery

William W. Chu , MD, PhD;

Intracoronary radiation therapy (IRT) for in-stent restenosis (ISR) in native coronary arteries and saphenous vein grafts (SVG) has substantially reduced the rate of recurrent restenosis compared with conventional percutaneous coronary...

Intracoronary radiation therapy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Patrick Ohlmann , MD;

Salah-Eddine Hassani , MD;

Esteban Escolar , MD;

Aleksandra Michalek , MD;

Ron Waksman , MD;

Neil J. Weissman , MD;

Gary S. Mintz , MD;

Lowell F. Satler , MD;

Impact of Remodeling on Cardiac Events in Patients with
Angiographically Mild Left Main Coronary Artery Disease

Sang Wook Kim , MD;

Anh B. Bui , MD;

The aorto-ostial junction has high elastic fiber content with significant elastic recoil.1-7 Ostial left main coronary artery (LMCA) stenoses have larger lumen areas with less plaque burden and more negative remodeling than non-ostial LMCA...

The aorto-ostial junction has...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Neil J. Weissman , MD;

Ron Waksman , MD;

Gary S. Mintz , MD;

Lowell F. Satler , MD;

Young Joon Hong , MD;

Sang Wook Kim , MD;

Li Lu , MS;

Anh B. Bui , MD;

Clinical Outcomes after Percutaneous Coronary Intervention with Drug-Eluting Stents in Dialysis Patients

Arterial remodeling is the geometric alteration of the arterial wall in response to atherogenesis. During the development and progression of atherosclerosis, the external elastic membrane cross-sectional area (EEM CSA) may increase (termed...

Arterial remodeling is the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

William W. Chu , MD, PhD;

Neil J. Weissman , MD;

Ron Waksman , MD;

Salah-Eddine Hassani , MD;

Zhenyi Xue , MS;

Roswitha M. Wolfram , MD;

Lowell F. Satler , MD;

Pramod K. Kuchulakanti , MD;

Natalie Gevorkian , MD;